Position in REGN
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$7,004,838,343
+$1,917,268,136 QoQ
Shares Held
9,075,153
+0.3% QoQ
Ownership
8.66%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.0003966875269210337.ToString("F0")%
Shared 6.983419453093519.ToString("F0")%
None 93.01618385937957.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,756,184 across 450 Biotechnology names. REGN ranks #2 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7,004,838,343 | 9,075,153 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,087,570,207 | 9,048,269 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,947,625,200 | 9,424,048 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $5,966,766,706 | 9,407,891 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $6,614,942,844 | 9,286,346 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,797,861,658 | 9,320,290 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,452,932,287 | 8,993,970 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,595,267,657 | 8,930,241 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,762,577,330 | 8,838,285 | Shares | Sole | 2024-03-11 | |
| 2023-09-30 | $7,240,817,672 | 8,798,505 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $6,364,136,082 | 8,857,038 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,273,522,258 | 8,852,121 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $6,293,159,004 | 8,722,448 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,957,433,866 | 8,648,125 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,066,424,489 | 8,570,745 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,839,021,676 | 8,360,330 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,152,265,390 | 8,158,515 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,884,577,832 | 8,071,281 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,451,373,894 | 7,969,660 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,785,314,931 | 8,000,412 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,831,651,692 | 7,931,220 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,471,650,266 | 7,988,228 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,892,531,127 | 7,844,995 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,132,492,654 | 6,415,230 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||